Parabilis appointed Craig Tendler as a director and member of its Science & Technology Committee, effective August 22, 2026.
Original SEC Filing: Parabilis Medicines, Inc. [ PBLS ] – 8-K – Aug. 25, 2026
Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC filings and other documents provided by Quartr.© 2026 TradingView, Inc.